Picture of Profound Medical logo

PRN — Profound Medical News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Canada Research Roundup: Manulife Financial, Mav Beauty Brands, Profound Medical, Suncor Energy

July 24 (Reuters) - Securities analysts revised their ratings and price targets on several
Canadian companies, including Manulife Financial, Mav Beauty Brands, Profound Medical and Suncor
Energy, on Tuesday. 
    
    HIGHLIGHTS    
     * Manulife Financial  MFC.TO : Canaccord Genuity starts with buy rating; price target C$29
     * Mav Beauty Brands  MAV.TO : Jefferies starts with buy rating; price target C$15
     * Profound Medical  PRN.TO : Canaccord Genuity starts with buy rating; price target C$2
     * Suncor Energy Inc  SU.TO : Mizuho starts with buy rating; C$61 price target    
        
Following is a summary of research actions on Canadian companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order. 
    
    
     * Great-West Lifeco  GWO.TO : Canaccord Genuity starts with buy rating; price target C$38
     * Industrial Alliance Insurance  IAG.TO : Canaccord Genuity starts with buy rating
     * Industrial Alliance Insurance  IAG.TO : Canaccord Genuity starts with PT C$60
     * Manulife Financial  MFC.TO : Canaccord Genuity starts with buy rating; price target C$29
     * Mav Beauty Brands  MAV.TO : Canaccord Genuity starts with buy rating; C$22 price target
     * Mav Beauty Brands  MAV.TO : Jefferies starts with buy rating; price target C$15
     * Parkland Fuel  PKI.TO : National Bank of Canada raises price target to C$37 from C$36
     * Profound Medical  PRN.TO : Canaccord Genuity starts with buy rating; price target C$2
     * Sun Life Financial  SLF.TO : Canaccord Genuity starts with hold rating
     * Sun Life Financial  SLF.TO : Canaccord Genuity starts with price target C$58
     * Suncor Energy Inc  SU.TO : Mizuho starts with buy rating; C$61 price target    
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))

Recent news on Profound Medical

See all news